Middle East & Africa Balloon Aortic Valvuloplasty Market Forecast to 2031 - Regional Analysis - by Product Type (Non Compliant Balloons and Semi Compliant Balloons)

Description

List of Tables

The Middle East & Africa balloon aortic valvuloplasty market was valued at US$ 9.99 million in 2023 and is expected to reach US$ 13.63 million by 2031; it is estimated to register a CAGR of 4.0% from 2023 to 2031.

Advancements in Aortic Valve Replacement Technologies Boost Middle East & Africa Balloon Aortic Valvuloplasty Market

Patients with heart conditions experience improved symptoms within a shorter period when treated with transcatheter procedures compared with surgical intervention. Minimally invasive surgical techniques, such as TAVI, have modernized the treatment of aortic stenosis due to advancements. TAVI is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Additionally, developments in design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and lowered the risk of complications. For instance, in January 2023, Abbott received FDA approval for the Navitor TAVI system to treat patients with severe aortic stenosis and those who are ineligible for open-heart surgery. Navitor has been newly introduced in the company's extensive transcatheter structural heart portfolio; it offers physicians and patients less invasive treatment alternatives for a range of serious heart conditions. Therefore, technological advancements are offering lucrative opportunities for the balloon aortic valvuloplasty market growth.

Middle East & Africa Balloon Aortic Valvuloplasty Market Overview

The increasing geriatric population, growing initiatives to create awareness about modern healthcare products, and efforts of organizations to offer advanced services to the population are the factors contributing to the balloon aortic valvuloplasty market growth in the Middle East & Africa.

As per the article "UAE Elevates Discussions on Healthy Ageing," published in June 2022, 1% of the UAE population was aged 60 and above in 2016. This figure is projected to reach 16% (2 million people) by 2050. In addition, as per the "Rights and Wellbeing of Older Persons in Saudi Arabia" report, the number of people aged 60 or more is predicted to increase five-fold during 2020-2050, rising from 2 million (5.9% of the total population) to 10.5 million (23.7% of the population). Also, the number of people aged 80 or more is expected to reach 1.6 million, i.e., 4% of the total population by 2050. As per the Statistics South Africa data, the country's estimated population included more than 5 million people aged 60 or above in 2022, representing 9.2% of the total South African population. In 2022, the elderly population of Iran totaled 9.2 million, representing 7.10% of the country's population. It is estimated that about 14% of Iran's population will become elderly by 2032, per the "Iran on the verge of aging crisis" article. As aged people are more susceptible to aortic stenosis, the growing geriatric population fuels the market for balloon aortic valvuloplasty.

In 2020, the Charlotte Maxeke Johannesburg Academic Hospital's Cardiology team performed the first TAVI procedure in the Gauteng Health public sector. The introduction of this service at the facility aids in mitigating the long waiting list for cardiac surgery combined with the poor outcomes of open-heart surgery in patients who pose a high risk. The first TAVI procedure in the world was performed in 2002, and seven years later, it was performed in South Africa. Since then, more than 2,000 South Africans have undergone TAVI; a vast majority of which is performed in the private sector. Valve disease continues to be prevalent in the UAE. According to a new study commissioned by Cleveland Clinic Abu Dhabi, an integral part of Mubadala Health, more than half of the country's residents have been affected by heart disease. In addition, the presence of cutting-edge technology and advanced healthcare facilities has introduced advanced treatment procedures in the region with better outcomes, which is likely to support the market growth. For instance, as per Khaleej times, in 2021, the Cleveland Clinic Abu Dhabi, UAE, performed transcatheter valve replacement for tricuspid valve regurgitation. Cleveland Clinic Abu Dhabi performs more than two-thirds of all heart disease cases in the UAE, with outcomes that are on par with those of the best programs in the world. The Department of Health - Abu Dhabi recently designated Cleveland Clinic Abu Dhabi as a Centre of Excellence for adult cardiac surgery to provide high-quality integrated cardiac surgery and structural heart disease interventions. Thus, the growing need for the treatment of heart diseases and the presence of advanced facilities propel the growth of the market in the region.

Middle East & Africa Balloon Aortic Valvuloplasty Market Revenue and Forecast to 2031 (US$ Million)

Middle East & Africa Balloon Aortic Valvuloplasty Market Segmentation

The Middle East & Africa balloon aortic valvuloplasty market is categorized into product type and country.

Based on product type, the Middle East & Africa balloon aortic valvuloplasty market is segmented into non compliant balloons and semi compliant balloons. The non compliant balloons segment held a larger market share in 2023.

By country, the Middle East & Africa balloon aortic valvuloplasty market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. Saudi Arabia dominated the Middle East & Africa balloon aortic valvuloplasty market share in 2023.

B Braun SE; TT Medical, Inc.; Balton; Becton Dickinson and Co; Edwards Lifesciences Corp; and Simeks are some of the leading companies operating in the Middle East & Africa balloon aortic valvuloplasty market.

Product Code: BMIRE00031482

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Middle East & Africa Balloon Aortic Valvuloplasty Market Landscape

4.1 Regional Pricing Analysis, By Product Type, 2023

5. Middle East & Africa Balloon Aortic Valvuloplasty Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Aortic Valve Stenosis
- 5.1.2 Increasing Demand for Minimally Invasive Procedures
5.2 Market Restraints
- 5.2.1 High Cost of Procedures
5.3 Market Opportunities
- 5.3.1 Advancements in Aortic Valve Replacement Technologies
5.4 Future Trends
- 5.4.1 Improvements in TAVI Combined with Research and Development
5.5 Impact of Drivers and Restraints:

6. Middle East & Africa Balloon Aortic Valvuloplasty Market - Global Market Analysis

6.1 Middle East & Africa Balloon Aortic Valvuloplasty Market Revenue (US$ Thousand), 2021-2031
6.2 Market Positioning Analysis, 2023

7. Middle East & Africa Balloon Aortic Valvuloplasty Market Analysis - by Product Type

7.1 Overview
7.2 Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast Analysis - by Product Type
7.3 Middle East & Africa Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis - by Product Type
7.4 Non Compliant Balloons
- 7.4.1 Overview
- 7.4.2 Non Compliant Balloons: Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
7.5 Semi Compliant Balloons
- 7.5.1 Overview
- 7.5.2 Semi Compliant Balloons: Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)

8. Middle East & Africa Balloon Aortic Valvuloplasty Market - Geographical Analysis

8.1 Middle East & Africa
- 8.1.1 Middle East & Africa: Balloon Aortic Valvuloplasty Market Breakdown, by Key Countries, 2023 and 2031 (%)
  - 8.1.1.1 Saudi Arabia: Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.1.1.1.1 Saudi Arabia: Middle East & Africa Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.1.1.1.2 Saudi Arabia: Middle East & Africa Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.1.1.2 South Africa: Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.1.1.2.1 South Africa: Middle East & Africa Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.1.1.2.2 South Africa: Middle East & Africa Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.1.1.3 United Arab Emirates: Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.1.1.3.1 United Arab Emirates: Middle East & Africa Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.1.1.3.2 United Arab Emirates: Middle East & Africa Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type
  - 8.1.1.4 Rest of Middle East & Africa: Middle East & Africa Balloon Aortic Valvuloplasty Market - Revenue and Forecast to 2031 (US$ Thousand)
    - 8.1.1.4.1 Rest of Middle East & Africa: Middle East & Africa Balloon Aortic Valvuloplasty Market Breakdown, by Product Type
    - 8.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Balloon Aortic Valvuloplasty Market - Volume and Forecast Analysis (Units) - by Product Type

9. Company Profiles

9.1 B Braun SE
- 9.1.1 Key Facts
- 9.1.2 Business Description
- 9.1.3 Products and Services
- 9.1.4 Financial Overview
- 9.1.5 SWOT Analysis
- 9.1.6 Key Developments
9.2 TT Medical, Inc.
- 9.2.1 Key Facts
- 9.2.2 Business Description
- 9.2.3 Products and Services
- 9.2.4 Financial Overview
- 9.2.5 SWOT Analysis
- 9.2.6 Key Developments
9.3 Balton
- 9.3.1 Key Facts
- 9.3.2 Business Description
- 9.3.3 Products and Services
- 9.3.4 Financial Overview
- 9.3.5 SWOT Analysis
- 9.3.6 Key Developments
9.4 Becton Dickinson and Co
- 9.4.1 Key Facts
- 9.4.2 Business Description
- 9.4.3 Products and Services
- 9.4.4 Financial Overview
- 9.4.5 SWOT Analysis
- 9.4.6 Key Developments
9.5 Edwards Lifesciences Corp
- 9.5.1 Key Facts
- 9.5.2 Business Description
- 9.5.3 Products and Services
- 9.5.4 Financial Overview
- 9.5.5 SWOT Analysis
- 9.5.6 Key Developments
9.6 Simeks
- 9.6.1 Key Facts
- 9.6.2 Business Description
- 9.6.3 Products and Services
- 9.6.4 Financial Overview
- 9.6.5 SWOT Analysis
- 9.6.6 Key Developments

10. Appendix

10.1 About The Insight Partners